NOVOGEN LIMITED (ACN 063 259 754) AND THE BANK OF NEW YORK MELLON As Depositary AND OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES Amended and Restated Deposit Agreement June 13, 2016Deposit Agreement • October 27th, 2016 • Novogen LTD • Pharmaceutical preparations • New York
AMENDED AND RESTATED DEPOSIT AGREEMENT dated as of June 13, 2016 among NOVOGEN LIMITED, a company incorporated under the laws of the Commonwealth of Australia (herein called the Company), THE BANK OF NEW YORK MELLON (formerly known as The Bank of New York), a New York banking corporation (herein called the Depositary), and all Owners and Holders (each as hereinafter defined) from time to time of American Depositary Shares issued hereunder.
EMPLOYMENT AGREEMENTEmployment Agreement • October 27th, 2016 • Novogen LTD • Pharmaceutical preparations
NOVOGEN LIMITED ACN 063 259 754Novogen LTD • October 27th, 2016 • Pharmaceutical preparations
HEADS OF AGREEMENT CLINICAL TRIAL FUNDINGNovogen LTD • October 27th, 2016 • Pharmaceutical preparations • New South Wales
Triaxial Pharmaceuticals Pty Ltd (Triaxial) Dear Shareholders, Amendment to Convertible Note Deed PollNovogen LTD • October 27th, 2016 • Pharmaceutical preparations
The Deed in which you are referred to as Convertible Note Holders (Note Holders) was signed by Novogen with the intention to extinguish the liability created by the Loan Agreement and transform your interest as creditor into an equity interest in Novogen, provided that the Company achieved defined milestones established in the schedule of the Deed (Milestone).
Novogen - Executive Employment Agreement General termsNovogen LTD • October 27th, 2016 • Pharmaceutical preparations • New South Wales
